Evidence map›Paper›PMID 32542416›Full record

ArticleEJNMMI radiopharmacy and chemistry2020

In vitro hypoxia responsiveness of [

Morten Busk, Michael R Horsman, Jens Overgaard, Steen Jakobsen

Abstract read
In one paragraph

Article in EJNMMI radiopharmacy and chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Morten BuskExperimental Clinical Oncology, Department of Oncology, Aarhus University Hospital (AUH), Palle Juul-Jensens Boulevard 99, 8200, Aarhus, Aarhus N, Denmark. morten@oncology.dk.ORCID http://orcid.org/0000-0001-5711-1017
Michael R HorsmanExperimental Clinical Oncology, Department of Oncology, Aarhus University Hospital (AUH), Palle Juul-Jensens Boulevard 99, 8200, Aarhus, Aarhus N, Denmark.
Jens OvergaardExperimental Clinical Oncology, Department of Oncology, Aarhus University Hospital (AUH), Palle Juul-Jensens Boulevard 99, 8200, Aarhus, Aarhus N, Denmark.
Steen JakobsenDepartment of Nuclear Medicine & PET centre, AUH, Aarhus, Denmark.

Funding

Kræftens Bekæmpelse R146-A9519-B699Kræftens Bekæmpelse R90-A6196
6 · The paper itself

Abstract

backgroundIn vitro experiments using radiolabeled molecules is fundamental for Positron emission tomography (PET) or single photon emission computed tomography (SPECT) tracer development and various metabolic assays, but no consensus on appropriate incubation conditions exists. Specifically, the use of shaking versus non-shaking conditions, cell number to medium volume and the choice of cell plating material may unintentionally influence cellular oxygenation and medium composition. This is problematic when testing the oxygen-dependence of tracers including

methodsTumor cells were seeded in a) Glass or standard Polystyrene Petri dishes or as b) discrete droplets in polystyrene Petri dishes or on 9 mm glass coverslips positioned in glass Petri dishes. When confluent, cells were pre-equilibrated for 2 h to 21%, 0.5% or 0% O

resultsThe influence of hypoxia on tracer retention varied widely among cell lines, but shaking-induced convection did not influence uptake. In contrast, hypoxia-driven [

conclusionsTracer retention was similar under stagnant and forced convection conditions suggesting that the former approach may be appropriate even when accurate control of oxygen and tracer availability is required. In contrast, conventional plasticware should be used with caution when studying tracers and drugs that are metabolized and retained or activated at low O

Indexed as

Cell substrataConvectionDiffusionHypoxiaIn vitro conditionsTracer availability

Identifiers

PMID32542416
PMCPMC7295868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.